tiprankstipranks
ZyVersa Therapeutics (ZVSA)
NASDAQ:ZVSA
US Market

ZyVersa Therapeutics (ZVSA) Cash flow

120 Followers

ZyVersa Therapeutics Cash Flow

ZVSA's free cash flow for Q4 2023 was $-2.79M. For the 2023 fiscal year, ZVSA's free cash flow was decreased by $-5.33M and operating cash flow was $-2.79M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21
Operating Cash Flow
$ -8.72M$ -8.72M$ -3.39M$ -428.83K
Investing Cash Flow
---$ -75.75M
Financing Cash Flow
$ 5.96M$ 5.96M$ 1.87M$ 77.11M
Cash Flow From Discontinued Operation
----
Other Cash Adjustment Inside Changein Cash
----
End Cash Position
$ -10.51M$ 3.14M$ 5.90M$ 928.39K
Income Tax Paid Supplemental Data
----
Interest Paid Supplemental Data
----
Issuance Of Capital Stock
$ 18.11M$ 18.11M-$ 78.20M
Issuance Of Debt
----
Repayment Of Debt
----
Free Cash Flow
$ -8.72M$ -8.72M$ -3.39M$ -428.83K
Domestic Sales
----
Foreign Sales
----
Currency in USD

ZyVersa Therapeutics Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis